Belatacept for the prophylaxis of organ rejection in kidney transplant patients: an evidence-based review of its place in therapy

BACKGROUND: Belatacept is a novel immunosuppressive therapy designed to improve clinical outcomes associated with kidney transplant recipients while minimizing use of calcineurin inhibitors (CNIs). METHODS: We searched for clinical trials related to administration of belatacept to kidney transplant...

Descripción completa

Detalles Bibliográficos
Autores principales: Hardinger, Karen L, Sunderland, Daniel, Wiederrich, Jennifer A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888760/
https://www.ncbi.nlm.nih.gov/pubmed/27307759
http://dx.doi.org/10.2147/IJNRD.S88816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888760/
https://www.ncbi.nlm.nih.gov/pubmed/27307759
http://dx.doi.org/10.2147/IJNRD.S88816

Ejemplares similares